|
| | Homocystine Basic information |
| Product Name: | Homocystine | | Synonyms: | 2-ammonio-4-[(3-ammonio-3-carboxylatopropyl)disulfanyl]butanoate;L-Homocystine;4,4'-Disulfanediylbis(2-aMinobutanoic acid);Product NameL-homocystine Synonyms;4,4'-dithiobis[2-aminobutyric] acid;4,4'-dithiobis[2-amino-Butanoic acid];L-4,4'-Dithiobis(2-aminobutyric acid);Butanoic acid, 4,4'-dithiobis[2-amino- | | CAS: | 462-10-2 | | MF: | C8H16N2O4S2 | | MW: | 268.35 | | EINECS: | 207-323-8 | | Product Categories: | | | Mol File: | 462-10-2.mol |  |
| | Homocystine Chemical Properties |
| Melting point | 281-284°C (dec.) | | alpha | 77 º (c=1%,1N HCl) | | Boiling point | 507.6±50.0 °C(Predicted) | | density | 1.443±0.06 g/cm3(Predicted) | | storage temp. | Keep in dark place,Inert atmosphere,Room temperature | | solubility | Aqueous Acid (Slightly). Aqueous Base (Slightly) | | form | Solid | | pka | 1.90±0.10(Predicted) | | color | White to Off-White |
| Safety Statements | 22-24/25 | | HS Code | 2930909899 |
| | Homocystine Usage And Synthesis |
| Uses | DL-Homocystine is used in the synthesis of potential antitumor agents through inhibition of L-asparagine. There is growing clinical evidence that elevated homocysteine levels are associated with an increased risk of venous and arterial thrombosis. | | Definition | ChEBI: An organic disulfide obtained by oxidative dimerisation of homocysteine. | | Purification Methods | dl-Homocystine crystallises in platelets from water with 1H2O and m 258-260o(dec), all operations should be carried out under N2. [Sudo J Chem Soc Jpn (Pure Chem Sect) 79 81, 86, 87 1958, Beilstein 4 IV 3199.] |
| | Homocystine Preparation Products And Raw materials |
|
